Dr Reddy : LongDR. Reddy’s Laboratories is showing a falling wedge pattern, which is typically considered a bullish reversal signal.
EMA Analysis: The price is trading above the 10, 20, and 200 EMAs, confirming the short-, medium-, and long-term bullish trend. A successful breakout above the descending trendline increases confidence in a sustained upward move. The recent crossover of 10 EMA above the 20 EMA further strengthens bullish momentum.
Volume Analysis: Bullish candles during the breakout phase are supported by rising volumes, indicating robust buying interest and solidifying the validity of the breakout. Volumes have reached above 430K, notably higher than previous averages, suggesting institutional participation.
RSI Analysis: The RSI is at 59.78, positioned securely above the midline (50) but still below any overbought condition (70). This level demonstrates enough momentum for further upside, leaving room for the rally to extend before any corrective move.
Trade Setup Recommendation
Parameter Value/Action
Entry: Above ₹1,285 after confirmation
Stop Loss: Below ₹1,265 (below breakout low/EMAs)
Target 1: ₹1,295–₹1,310 (near-term resistance)
Target 2: ₹1,340 (extension, if momentum holds)
RSI Condition: Hold as long as RSI remains < 70
Buy on confirmation above ₹1,285 with the given stop loss and targets; volumes and RSI both support entry at current levels.
If price closes below the 200 EMA or RSI falls below 50, reconsider the bullish trade. This setup leverages strong technical signals and is suitable for short- to medium-term trading.
The analysis and trade setup provided above are for educational purposes only and do not constitute investment advice. Always conduct independent research, consider personal financial circumstances, and consult with a qualified financial advisor before making trading or investment decisions. Trading stocks and financial instruments involve risks, including the possibility of losing capital, and past performance does not guarantee future results
RDDA trade ideas
DRREDDYDRREDDY - The stock is showing strength as it trades above all the key EMAs, indicating bullish momentum. A clear volume pickup is visible, adding confirmation to the move.
After a healthy retracement, price has broken above the immediate resistance zone. If it sustains this breakout, there’s a strong probability of an extended upside move.
The last hammer candle took solid support at the 200 EMA, which often acts as a major trend indicator, this bounce further validates the underlying strength.
Defining stop-loss and position sizing is crucial to manage downside risk, even in strong setups.
✅ If you like my analysis, please follow me as a token of appreciation :)
in.tradingview.com/u/SatpalS/
📌 For learning and educational purposes only, not a recommendation. Please consult your financial advisor before investing.
Drreddy is forming a diamond pattern Dr. Reddy’s
⚖️ Diamond/symmetrical triangle pattern visible.
✅ EMAs rising on daily, RSI ~60.
🚩 Weekly chart still consolidating → needs close above ₹1280.
🎯 Target zones: ~₹1317
, ₹1359, ₹1400.
🛑 Stop-loss: ₹1255.
Macro tailwinds: weak dollar, lower inflation, stable growth → supportive for emerging markets and defensive/healthcare plays.
Dr. Reddy’s – A Healthy Dose of GrowthFundamental Overview
Dr. Reddy’s Laboratories Ltd. (NSE: DRREDDY) is one of India’s leading pharmaceutical companies with a strong global presence across generics, active pharmaceutical ingredients (APIs), biosimilars, and specialty medicines. The company’s diversified portfolio across the U.S., India, Russia, and emerging markets helps cushion against regional risks.
Financial Highlights (FY 2024–25)
Revenue Growth: Consistent YoY revenue expansion driven by strong U.S. generics sales and India formulations.
Profitability: Robust EBITDA margins supported by cost optimization and efficient R&D allocation.
R&D Spending: Around 7–8% of revenue, strengthening the pipeline for complex generics and biosimilars.
Debt Profile: Very low leverage with strong cash flows, providing balance sheet resilience.
Key Ratio Metrics
P/E Ratio: ~20.5 (reasonable vs. sector average ~24).
P/B Ratio: ~4.2 (slightly premium, reflecting brand strength and consistent profitability).
ROE: ~17.4% (efficient capital utilization).
ROCE: ~20% (solid operational performance).
Debt-to-Equity: ~0.05 (nearly debt-free).
Operating Margin: ~24% (healthy compared to peers).
Fundamental Sentiment: Positive — strong balance sheet, high return ratios, and steady global presence make Dr. Reddy’s a long-term compounding story.
Sentimental Analysis
US Tariff Policy Impact
The recent U.S. administration discussions on drug pricing reforms and import tariffs have mixed implications.
While tariff hikes on Chinese raw materials increase input costs, Indian pharma companies like Dr. Reddy’s can benefit from being an alternate sourcing hub.
U.S. remains the largest revenue contributor (~40%), so regulatory/tariff relief on generics is a net positive.
Technical Insights
200 SMA Support: Price has reclaimed the 200-day SMA (~₹1,238), signaling a trend reversal.
Parallel Channel Breakout: Breakout from the downward channel suggests a bullish reversal.
Demand Zone: Weekly demand zone at ₹1,129–₹1,189 provided strong accumulation support.
Reversal Zone: ₹1,204–₹1,238 aligned with the 200 SMA acted as a crucial pivot zone.
Volume Action
Latest Volume: 2.01M shares
30-Day Average Volume: 1.42M shares
The 40% higher-than-average volume confirms institutional participation and validates the breakout.
Key Resistance Levels
R1: ₹1,334
R2: ₹1,378
R3: ₹1,453
Technical Sentiment: Bullish momentum supported by above-average volume. Sustained close above ₹1,283 can trigger the next rally.
Conclusion
Dr. Reddy’s Laboratories stands out as a fundamentally strong and technically improving stock. With robust financials, negligible debt, consistent R&D spending, and favorable sentiment from U.S. tariff realignments and GST clarity, the company is well positioned for sustainable growth.
Short-term View: Bullish above ₹1,283 with targets of ₹1,334–₹1,453.
Long-term View: Strong fundamentals make it a compounding story in the Indian pharma sector.
Disclaimer: lnkd.in
DRREDDY – Triangle Breakout in Play📊 DRREDDY – Technical & Educational Snapshot
Ticker: NSE: DRREDDY | Sector: 💊 Pharma
CMP: ₹1,276.60 ▲ (+2.51% | 22 Aug 2025)
Rating (for learning purpose): ⭐⭐⭐⭐ (Moderately Bullish)
Pattern Observed: 📈 Triangle Breakout with Volume Confirmation
📰 Sentiment Analysis
👉 Overall Sentiment: Positive ✅
• Bullish Drivers: Breakout from triangle formation, Morning Star on daily, bullish PinBar on monthly, strong Q1 results with revenue & profit growth, and renewed interest in pharma sector due to healthcare demand.
• Risks (Bearish Case): Any failure to sustain above ₹1,250 or renewed pressure from regulatory issues/patent challenges could trigger pullbacks.
• Short-term Outlook: Strong breakout with momentum, but some cooling-off likely due to Stochastic overbought levels.
• Long-term Outlook: Positive — consistent financial performance, strong pharma pipeline, and robust technical structure suggest higher upside potential.
📊 Technical Snapshot
DRREDDY has broken out from a triangle formation, supported by a Morning Star candlestick on the daily timeframe and a Bullish PinBar on the monthly chart — both strong reversal cues. A bullish Supertrend, RSI breakout, and Bollinger Band expansion signal renewed buying interest. Volume above the 20-SMA average further validates the breakout, suggesting institutional participation. While momentum is strong, Stochastic is near overbought, which means short-term pullbacks cannot be ruled out. However, as long as price sustains above key support zones, the broader trend bias remains upward.
📊 Volume Check
🔹 Current Volume: 2.01M
🔹 20 SMA Volume: 1.61M ✅
💥 Above-average participation → confirms breakout reliability with demand expansion.
💡 Interpretation: Higher-than-average volumes in breakout zones indicate broader market participation and improve the chances of trend continuation.
💡 Learnings
Breakouts from consolidation patterns like triangles tend to extend into trending moves when supported by momentum indicators (RSI + MACD). Elevated CCI levels indicate consistent buying pressure, but traders should remain alert to possible short pullbacks, especially when Stochastic enters the overbought zone. Defining a stop-loss and invalidation level is key for disciplined trade management.
📌 Key Levels
Resistance: 1292 | 1308 | 1334
Support: 1251 | 1225 | 1209
Fibonacci Levels: 1138.50 | 1195.40 | 1230.65 | 1259.10 | 1287.55 | 1328.10 | 1379.70
🎯 STWP Learning Reference
• Observed breakout zone: ~1281.8
• Key support level: ~1236
• Upside reference zones (if momentum continues): 1327 | 1372
• Pullback watch zone: 1224–1230 (where demand has earlier emerged)
• Invalidation reference: Below 1195 (trend may weaken)
⚠️ Disclaimer – Please Read Carefully
The information shared here is meant purely for learning and awareness. It is not a buy or sell recommendation and should not be taken as investment advice. I am not a SEBI-registered investment advisor, and all views expressed are based on personal study, chart patterns, and publicly available market data.
Trading — whether in stocks or options — carries risk. Markets can move unexpectedly, and losses can sometimes exceed the money you have invested. Past performance or past setups do not guarantee future results.
If you are a beginner, treat this as a guide to understand how the market works — practice on paper trades before risking real money. If you are experienced, always assess your own risk, position sizing, and strategy suitability before entering trades.
Consult a SEBI-registered financial advisor before making any real trading decision. By engaging with this content, you acknowledge full responsibility for your trades and investments.
💬 Found this useful?
🔼 Give this post a Boost to help more traders discover clean, structured learning.
✍️ Drop your thoughts, questions, or setups in the comments — let’s grow together!
🔁 Share with fellow traders and beginners to spread awareness.
✅ Follow simpletradewithpatience for beginner-friendly setups, price action insights & disciplined trading content.
🚀 Stay Calm. Stay Clean. Trade With Patience.
Trade Smart | Learn Zones | Be Self-Reliant 📊
Dr. Reddy’s Breakout + Bullish Stochastic + Volume Surge = ₹1307🔍 TECHNICAL HIGHLIGHTS:
📉 DESCENDING WEDGE BREAKOUT:
Price has decisively broken above the wedge resistance, signaling a trend reversal.
🚀 GAP-UP OPENING:
Signals aggressive buyer interest and bullish sentiment.
🔄 STOCHASTIC OSCILLATOR:
Fast %K line has crossed above the slow %D line in the oversold zone, indicating momentum is shifting to the upside.
🔊 VOLUME SURGE:
Heavy volume during breakout confirms strong buying pressure and likely institutional participation.
🎯 TRADE SETUP:
✅ PROFIT TARGET : ₹1307
❌ STOP LOSS: ₹1221
📌 CONCLUSION:
All indicators align for a potential bullish rally. With pattern confirmation, momentum support, and volume validation, this setup looks promising. Watch for follow-through price action and volume consistency.
DR REDDY S LABORATORIESAs of June 6, 2025, Dr. Reddy's Laboratories Ltd. (NSE: DRREDDY) is trading at approximately ₹1,290.60, reflecting a 3.04% increase over the previous day.
📊 Daily Pivot Points (Classic Method)
Based on the previous day's high, low, and close, the daily pivot levels are:
Pivot Point: ₹1,307.93
Support Levels:
S1: ₹1,286.07
S2: ₹1,268.73
S3: ₹1,246.87
Resistance Levels:
R1: ₹1,325.27
R2: ₹1,347.13
R3: ₹1,369.99
📈 Fibonacci Pivot Points
Using Fibonacci calculations, the levels are:
Pivot Point: ₹1,307.93
Support Levels:
S1: ₹1,286.07
S2: ₹1,268.73
S3: ₹1,246.87
Resistance Levels:
R1: ₹1,325.27
R2: ₹1,347.13
R3: ₹1,369.99
🔍 Camarilla Pivot Points
Derived using the Camarilla method:
Pivot Point: ₹1,286.07
Support Levels:
S1: ₹1,269.04
S2: ₹1,279.82
S3: ₹1,283.41
Resistance Levels:
R1: ₹1,294.19
R2: ₹1,297.79
R3: ₹1,301.38
📌 Trading Insights
Immediate Support: ₹1,286.07 (Classic S1)
Immediate Resistance: ₹1,325.27 (Classic R1)
Traders may consider these levels for setting stop-loss and take-profit orders. A break above ₹1,325.27 could signal bullish momentum, while a drop below ₹1,286.07 might indicate bearish pressure.
DRREDDY – 15 Min Chart AnalysisDRREDDY – 15 Min Chart Analysis 🧪📈
Currently trading within the pitchfork channel. 🪓
Use the fork structure for identifying future support & resistance levels. 🔍📊
A bullish breakout is on the cards if price breaks above the pitchfork – keep a close eye! 👀✨
Looking strong – momentum building! 🚀🔥
DR REDDY GAP DOWN IN 3rd WAVEwe clearly see GAP DOWN in 3rd wave of the 5 waves of the C wave. What does this indicates? A fall to complete the 3rd wave was quick. we are done with 3rd wave and in the process to complete the 4th wave.
Possibilities:
*) Downward it can go to 1148-1160 to complete the 5th wave.
*) It may close the 3rd wave Gap before resuming its downward Journey to complete the 4th wave. (Less Probability)
In Either case I would prefer not to enter any new position and wait for the right opportunity.
Disclaimer: I am not SEBI registered Member. This is Strictly for educational purpose only.
Dr. Reddy's: Cypher Pattern and Support Level AnalysisDr. Reddy's Laboratories has formed a cypher pattern and is finding support around the ₹1200 level, after a recent 15% fall. Dr. Reddy's shares are trading at ₹1250.20, reflecting a 1.85% change for the day1. The company exhibits low volatility compared to the market, with a six-month beta of 0.2055
DR Reddy's - Two Possible ScenarioCurrently Stock in mild down trend to sideways
Area 1310 - 1330 become crucial
Any close above 1330 will take the stock back to 1400 & higher
Any close below 1310 will make it bearish for quite some time
Then it will give an opportunity to sell on pull back
Downside targets of 1270 & 1250 may follow
Will wait for close in both the scenario
Resilient Sector Stock and breakout of important resistance Rational:
1. Pharma sector is one of the resilient sector in current market fall.
2. Returning to this price level after 2 months. For the third time at this level and trying to breach the level for last 3 days.
3. Entry at the breakout of this level with SL of around 4.4%. Entry : 1370; SL: 1310; Target: Trail as per 9 EMA.
Dr. Reddy's Laboratories LtdThe daily chart of Dr. Reddy's Laboratories Ltd (DRREDDY) on the NSE indicates a bullish setup, with the price trading above the 50-day SMA (1268.29), 200-day SMA (1275.84), and 21-day EMA (1261.02). A downward trendline highlights resistance near 1368, while an upward trendline indicates accumulation with higher lows. The RSI at 69.74 suggests strong momentum, and the MACD shows a bullish crossover, confirming upward momentum. Aggressive traders can consider entering on a breakout above 1368, targeting 1450–1500, with a stop-loss below 1330. Conservative traders may wait for a pullback to the 1275–1285 support zone (near the 200-day SMA) or the upward trendline around 1300–1310, targeting 1380–1420, with a stop-loss below 1270. Volume is rising, supporting the recent price action.